Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Capital Employed (2021 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Return on Capital Employed data on record, last reported at 0.28% in Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 6.0% year-over-year to 0.28%; the TTM value through Dec 2025 reached 0.28%, down 6.0%, while the annual FY2025 figure was 0.25%, 6.0% down from the prior year.
  • Return on Capital Employed reached 0.28% in Q4 2025 per MRVI's latest filing, up from 0.37% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.33% in Q1 2022 and bottomed at 0.37% in Q2 2025.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.04% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: increased 18bps in 2022, then crashed -33bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.31% in 2021, then decreased by -13bps to 0.27% in 2022, then crashed by -107bps to 0.02% in 2023, then tumbled by -1129bps to 0.22% in 2024, then fell by -30bps to 0.28% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.28% in Q4 2025, 0.37% in Q2 2025, and 0.29% in Q1 2025.